Collectively, mitochondrial dysfunction plays a pivotal role in the development of DCM, while modulating PPARα activity via PGC1 is a promising approach to attenuate mitochondrial dysfunction. This evidence concerns the gene PPARA and familial dilated cardiomyopathy.